Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

An attenuated Salmonella oral DNA vaccine prevents the growth of hepatocellular carcinoma and colon cancer that express α-fetoprotein

Abstract

Antitumor vaccination therapies using attenuated Salmonella typhimurium carrying plasmid DNA encoding tumor-associated antigens are currently under preclinical development. In the present study, we first established a useful method to facilitate in vivo monitoring of attenuated S. typhimurium uptake using a bioluminescent lux gene operon plasmid. Following transformation with the lux gene operon construct, mice were fed with various amounts of attenuated S. typhimurium-lux to monitor in vivo clearance over a period of 24 h. We found that the ingested attenuated S. typhimurium-lux cells were almost cleared out 9 h postfeeding, as judged by a significant decrease in bioluminescence. We further examined the therapeutic efficacy of vaccination using attenuated S. typhimurium carrying the mouse α-fetoprotein (AFP) gene against a cancer line CT26-murine α-feto protein (mAFP) that stably expresses AFP and mouse hepatocellular carcinoma (HCC) Hepa1-6. Attenuated S. typhimurium oral DNA vaccine was found to promote protective immunity against both CT26-mAFP and Hepa1-6 tumor cells growth. The oral DNA vaccine significantly increased the life span of tumor-challenged mice in both tumor models. Together, these results suggest that vaccination with the attenuated S. typhimurium oral DNA vaccine that carries the AFP gene could be a promising strategy to prevent HCC development.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 2
Figure 1
Figure 3
Figure 4

Similar content being viewed by others

References

  1. Schafer DF, Sorrell MF . Hepatocellular carcinoma. Lancet 1999; 353: 1253–1257.

    Article  CAS  PubMed  Google Scholar 

  2. Hoofnagle JH . Hepatocellular carcinoma: summary and recommendations. Gastroenterology 2004; 127: S319–S323.

    Article  PubMed  Google Scholar 

  3. Butterfield LH . Immunotherapeutic strategies for hepatocellular carcinoma. Gastroenterology 2004; 127: S232–S241.

    Article  CAS  PubMed  Google Scholar 

  4. Deutsch HF . Chemistry and biology of alpha-fetoprotein. Adv Cancer Res 1991; 56: 253–312.

    Article  CAS  PubMed  Google Scholar 

  5. Hanke P, Serwe M, Dombrowski F, Sauerbruch T, Caselmann WH . DNA vaccination with AFP-encoding plasmid DNA prevents growth of subcutaneous AFP-expressing tumors and does not interfere with liver regeneration in mice. Cancer Gene Ther 2002; 9: 346–355.

    Article  CAS  PubMed  Google Scholar 

  6. Butterfield LH, Koh A, Meng W, Vollmer CM, Ribas A, Dissette V et al. Generation of human T-cell responses to an HLA-A2.1-restricted peptide epitope derived from alpha-fetoprotein. Cancer Res 1999; 59: 3134–3142.

    CAS  PubMed  Google Scholar 

  7. Butterfield LH, Meng WS, Koh A, Vollmer CM, Ribas A, Dissette VB et al. T cell responses to HLA-A*0201-restricted peptides derived from human alpha fetoprotein. J Immunol 2001; 166: 5300–5308.

    Article  CAS  PubMed  Google Scholar 

  8. Butterfield LH, Ribas A, Meng WS, Dissette VB, Amarnani S, Vu HT et al. T-cell responses to HLA-A*0201 immunodominant peptides derived from alpha-fetoprotein in patients with hepatocellular cancer. Clin Cancer Res 2003; 9: 5902–5908.

    CAS  PubMed  Google Scholar 

  9. Vollmer Jr CM, Eilber FC, Butterfield LH, Ribas A, Dissette VB, Koh A et al. Alpha-fetoprotein-specific genetic immunotherapy for hepatocellular carcinoma. Cancer Res 1999; 59: 3064–3067.

    CAS  PubMed  Google Scholar 

  10. Meng WS, Butterfield LH, Ribas A, Dissette VB, Heller JB, Miranda GA et al. Alpha-fetoprotein-specific tumor immunity induced by plasmid prime-adenovirus boost genetic vaccination. Cancer Res 2001; 61: 8782–8786.

    CAS  PubMed  Google Scholar 

  11. Stocker BA . Aromatic-dependent salmonella as anti-bacterial vaccines and as presenters of heterologous antigens or of DNA encoding them. J Biotechnol 2000; 83: 45–50.

    Article  CAS  PubMed  Google Scholar 

  12. Reisfeld RA, Niethammer AG, Luo Y, Xiang R . DNA vaccines suppress tumor growth and metastases by the induction of anti-angiogenesis. Immunol Rev 2004; 199: 181–190.

    Article  CAS  PubMed  Google Scholar 

  13. Darji A, Guzman CA, Gerstel B, Wachholz P, Timmis KN, Wehland J et al. Oral somatic transgene vaccination using attenuated S. typhimurium. Cell 1997; 91: 765–775.

    Article  CAS  PubMed  Google Scholar 

  14. Luo Y, Zhou H, Mizutani M, Mizutani N, Reisfeld RA, Xiang R . Transcription factor Fos-related antigen 1 is an effective target for a breast cancer vaccine. Proc Natl Acad Sci USA 2003; 100: 8850–8855.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Yu YA, Shabahang S, Timiryasova TM, Zhang Q, Beltz R, Gentschev I et al. Visualization of tumors and metastases in live animals with bacteria and vaccinia virus encoding light-emitting proteins. Nat Biotechnol 2004; 22: 313–320.

    Article  CAS  PubMed  Google Scholar 

  16. Mahajan SD, Aalinkeel R, Schwartz SA, Chawda RP, Nair MPN . Effector cell mediated cytotoxicity measured by intracellular Granzyme B release in HIV infected subjects. Biol Proc Online 2003; 5: 182–188.

    Article  CAS  Google Scholar 

  17. Niethammer AG, Xiang R, Becker JC, Wodrich H, Pertl U, Karsten G et al. A DNA vaccine against VEGF receptor 2 prevents effective angiogenesis and inhibits tumor growth. Nat Med 2002; 8: 1369–1375.

    Article  CAS  PubMed  Google Scholar 

  18. Francis KP, Joh D, Bellinger-Kawahara C, Hawkinson MJ, Purchio TF, Contag PR . Monitoring bioluminescent Staphylococcus aureus infections in living mice using a novel luxABCDE construct. Infect Immun 2000; 68: 3594–3600.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Zhao M, Yang M, Li XM, Jiang P, Baranov E, Li S et al. Tumor-targeting bacterial therapy with amino acid auxotrophs of GFP-expressing Salmonella typhimurium. Proc Natl Acad Sci USA 2005; 102: 755–760.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Wang XP, Liu GZ, Song AL, Li HY, Liu Y . Antitumor immunity induced by DNA vaccine encoding alpha-fetoprotein/heat shock protein 70. World J Gastroenterol 2004; 10: 3197–3200.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Tian G, Yi JL, Xiong P . Antitumor immunopreventive effect in mice induced by DNA vaccine encoding a fusion protein of alpha-fetoprotein and CTLA4. World J Gastroenterol 2004; 10: 200–204.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Saeki A, Nakao K, Nagayama Y, Yanagi K, Matsumoto K, Hayashi T et al. Diverse efficacy of vaccination therapy using the alpha-fetoprotein gene against mouse hepatocellular carcinoma. Int J Mol Med 2004; 13: 111–116.

    CAS  PubMed  Google Scholar 

  23. Xiang R, Lode HN, Chao TH, Ruehlmann JM, Dolman CS, Rodriguez F et al. An autologous oral DNA vaccine protects against murine melanoma. Proc Natl Acad Sci USA 2000; 97: 5492–5497.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Xiang R, Mizutani N, Luo Y, Chiodoni C, Zhou H, Mizutani M et al. A DNA vaccine targeting survivin combines apoptosis with suppression of angiogenesis in lung tumor eradication. Cancer Res 2005; 65: 553–561.

    CAS  PubMed  Google Scholar 

  25. Weth R, Christ O, Stevanovic S, Zoller M . Gene delivery by attenuated Salmonella typhimurium: comparing the efficacy of helper versus cytotoxic T cell priming in tumor vaccination. Cancer Gene Ther 2001; 8: 599–611.

    Article  CAS  PubMed  Google Scholar 

  26. Grimm CF, Ortmann D, Mohr L, Michalak S, Krohne TU, Meckel S et al. Mouse alpha-fetoprotein-specific DNA-based immunotherapy of hepatocellular carcinoma leads to tumor regression in mice. Gastroenterology 2000; 119: 1104–1112.

    Article  CAS  PubMed  Google Scholar 

  27. Voisey CR, Marincs F . Elimination of internal restriction enzyme sites from a bacterial luminescence (luxCDABE) operon. Biotechniques 1998; 24: 56–58.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We thank Dr Hui-Wen Lo at Department of Molecular and Cellular Oncology and Sandra Young at Department of Scientific Publication at the University of Texas MD Anderson Cancer Center for editing the manuscript. This work was supported by Grants from SPORE in Ovarian Cancer P50CA83639, SPORE in Pancreatic Cancer P20CA101936 and Kadoorie Charitable Foundation (to M-C Hung). J-YH was partially supported by the Kaohsiung Medical University Hospital, Taiwan.

Author information

Authors and Affiliations

Corresponding author

Correspondence to M-C Hung.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chou, CK., Hung, JY., Liu, JC. et al. An attenuated Salmonella oral DNA vaccine prevents the growth of hepatocellular carcinoma and colon cancer that express α-fetoprotein. Cancer Gene Ther 13, 746–752 (2006). https://doi.org/10.1038/sj.cgt.7700927

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue date:

  • DOI: https://doi.org/10.1038/sj.cgt.7700927

Keywords

This article is cited by

Search

Quick links